Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Yasuda

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|December 22, 2005
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical courseMakiko Mizukami, Takeshi Hanagiri, Tetsuro Baba, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2009
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancerYoshiki Shigematsu, Takeshi Hanagiri, Hironobu Shiota, et al.
Clinical Lung Cancer|November 6, 2012
Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancerMasaru Takenaka, Takeshi Hanagiri, Shinji Shinohara, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2008
Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in JapanYoshika Nagata, Takeshi Hanagiri, Makiko Mizukami, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapyYoshinobu Ichiki, Takeshi Hanagiri, Mitsuhiro Takenoyama, et al.
Anticancer Research|April 12, 2003
A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patientsTsunehiro Oyama, Toshihiro Kawamoto, Koji Matsuno, et al.
Anticancer Research|July 11, 2006
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growthMakiko Mizukami, Takeshi Hanagiri, Yoshiki Shigematsu, et al.
International Journal of Cancer|November 30, 2006
Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lungMasakazu Sugaya, Mitsuhiro Takenoyama, Yoshiki Shigematsu, et al.
Cancer Research|September 7, 2007
Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency miceMakiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 7, 2003
Pleomorphic carcinoma: report of a case with massive pleural effusion and asbestos particlesTsunehiro Oyama, Toshihiro Osaki, Toyohi Isse, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|December 22, 2005
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical courseMakiko Mizukami, Takeshi Hanagiri, Tetsuro Baba, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2009
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancerYoshiki Shigematsu, Takeshi Hanagiri, Hironobu Shiota, et al.
Clinical Lung Cancer|November 6, 2012
Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancerMasaru Takenaka, Takeshi Hanagiri, Shinji Shinohara, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2008
Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in JapanYoshika Nagata, Takeshi Hanagiri, Makiko Mizukami, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapyYoshinobu Ichiki, Takeshi Hanagiri, Mitsuhiro Takenoyama, et al.
Anticancer Research|April 12, 2003
A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patientsTsunehiro Oyama, Toshihiro Kawamoto, Koji Matsuno, et al.
Anticancer Research|July 11, 2006
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growthMakiko Mizukami, Takeshi Hanagiri, Yoshiki Shigematsu, et al.
International Journal of Cancer|November 30, 2006
Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lungMasakazu Sugaya, Mitsuhiro Takenoyama, Yoshiki Shigematsu, et al.
Cancer Research|September 7, 2007
Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency miceMakiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 7, 2003
Pleomorphic carcinoma: report of a case with massive pleural effusion and asbestos particlesTsunehiro Oyama, Toshihiro Osaki, Toyohi Isse, et al.
Pageof 9